Related Experiment Video
Updated: Jul 3, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Cognitive impairment in the elderly diabetics
M Motta1, S Sorace, S Restuccia
1Institute of Internal Medicine and Geriatrics, Catania University, Ospedale Cannizzaro, Via Messina, 829, l-95126 Catania, Italy.
Archives of Gerontology and Geriatrics
|January 1, 1996
Summary
Diabetes in elderly patients is linked to cognitive impairment and memory loss. This study investigates the role of metabolic changes and cerebrovascular deficits in diabetic seniors, exploring the unclear mechanisms behind these cognitive issues.
Area of Science:
- Gerontology
- Neurology
- Endocrinology
Background:
- Cognitive impairment, particularly memory loss, is frequently observed in elderly individuals with diabetes mellitus.
- The precise mechanisms linking diabetes to cognitive decline in older adults remain incompletely understood.
- Metabolic dysregulation, including fluctuations in blood glucose levels (hypoglycemia and hyperglycemia), is implicated in affecting cognitive function.
Purpose of the Study:
- To investigate the relationship between diabetes and cognitive impairment in the elderly population.
- To explore the potential role of metabolic changes in diabetes-related cognitive deficits.
- To examine cerebrovascular deficits in elderly patients with diabetes as a preliminary step in understanding underlying mechanisms.
Main Methods:
- This research presents preliminary data from an ongoing study.
- The study focuses on elderly patients diagnosed with diabetes.
- Cerebrovascular deficits are being assessed in the study cohort.
Main Results:
- Preliminary data from an ongoing study is being reported.
- The study is examining elderly diabetic patients.
- The focus is on identifying cerebrovascular deficits.
Conclusions:
- The study aims to shed light on the mechanisms connecting diabetes and cognitive impairment in the elderly.
- Understanding metabolic changes and cerebrovascular health is crucial for addressing cognitive issues in diabetic seniors.
- Further research is needed to elucidate these complex relationships.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...